Records containing: T2DM (Type 2 Diabetes Mellitus)

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2019-09-12
A Randomized, Placebo-controlled ,Double-blind, Phase IIa Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
CLINICAL_TRIALS study record update · 2019-07-18
A Multi-center, Randomized, Double-Blind, Placebo-controlled, Phase 2, Therapeutic Exploratory Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
CLINICAL_TRIALS study record update · 2019-06-20
Clinical and Epidemiological Characteristics and Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus Under Routine Clinical Practice
CLINICAL_TRIALS study record update · 2019-01-03
Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction
CLINICAL_TRIALS study record update · 2018-03-27
ClinicalTrials.gov study NCT03050229
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2017-08-22
Effect of Viscous Soluble Fibres on Body Weight Parameters: Review and Meta-analyses
CLINICAL_TRIALS study record update · 2017-07-28
Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
CLINICAL_TRIALS study record update · 2017-05-16
The Influence of AMPK Subunit Alpha (PRKAA2) Genetic Polymorphisms With Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy